We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report: US Reimbursement System Hinders Diagnostics Development
Report: US Reimbursement System Hinders Diagnostics Development
February 9, 2011
Some innovative diagnostic tests may never make it to market in the U.S. unless changes are made to the country’s reimbursement system, the Biotechnology Industry Organization (BIO) says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor